DEFINITIVE PROXY STATEMENT

Company

Viridian Therapeutics, Inc.\DE

Filed

May 26, 2015

Period of Report

June 18, 2015

Accession Number

0001171843-15-003066

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →